A discovery has opened up the possibility of drugs to promote an enzyme activity, which protects against the consequences of aging on metabolic health, including type 2 diabetes.

TOP INSIGHT
Researchers have shown that the levels of NOX4 in skeletal muscle are directly related to the age-associated decline in insulin sensitivity.
One of the main reasons for the increased prevalence of type 2 diabetes with age is the development of insulin resistance, or an inability for the body to respond to insulin, and this is often caused by reduced physical activity as we age.
However, the precise mechanisms by which physical inactivity facilitates the development of insulin resistance have remained a mystery.
Now researchers have discovered that enzymes involved in physical activity enhance insulin responsiveness and in turn promote metabolic health. This mechanism has the potential to be targeted by drugs to protect against aging.
Researchers reveal that reductions in skeletal muscle reactive oxygen species (ROS) generation during aging is instrumental in the development of insulin resistance.
In a paper published in the journal, Science Advances, they have shown how an enzyme called NOX-4 is essential for exercise-induced ROS and the adaptive responses that drive metabolic health.
This study has shown that skeletal muscle NOX4 abundance is decreased with aging and this leads to a reduction in insulin sensitivity in animal models.
Triggering the activation of the adaptive mechanisms orchestrated by NOX4 with drugs might enhance key aspects of aging, including the development of insulin resistance and type 2 diabetes.
One of these compounds is found naturally in cruciferous vegetables, such as broccoli or cauliflower, though the amount needed for anti-aging effects might be more than many would be willing to consume.
Source-Medindia
MEDINDIA




Email










